The development of macrophage-mediated cell therapy to improve skeletal muscle function after injury

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Rybalko, Viktoriya ^a   Hsieh, Pei Ling ^a   Merscham Banda, Melissa ^a   Suggs, Laura J ^b   Farrar, Roger P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; SOMATOMEDIN; CD45 ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL THERAPY; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HISTOLOGY; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCLE TISSUE; MUSCLE TONE; NONHUMAN; POLARIZATION; REPERFUSION INJURY; ANIMAL; BODY WEIGHT; BONE MARROW CELL; C57BL MOUSE; CELL POLARITY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; INJURIES; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; STAINING; TRANSPLANTATION; WOUND HEALING;

ANIMALS; ANTIGENS, CD45; BODY WEIGHT; BONE MARROW CELLS; CELL POLARITY; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; STAINING AND LABELING; WOUND HEALING;

EID: 84957558085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145550     Document Type: Article

References (59)

1. Ten Broek RW, Grefte S, Von den Hoff JW. Regulatory factors and cell populations involved in skeletal muscle regeneration. Journal of cellular physiology. 2010; 224(1):7-16. doi: 10.1002/jcp.22127 PMID: 20232319.
2. Tidball JG. Mechanisms of muscle injury, repair, and regeneration. Comprehensive Physiology. 2011; 1(4):2029-62. doi: 10.1002/cphy.c100092 PMID: 23733696.
3. Nathan C. Points of control in inflammation. Nature. 2002; 420(6917):846-52. doi: 10.1038/nature01320 PMID: 12490957.
4. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovascular surgery. 2002; 10(6):620-30. PMID: 12453699.
5. Chen XK, Rathbone CR, Walters TJ. Treatment of tourniquet-induced ischemia reperfusion injury with muscle progenitor cells. The Journal of surgical research. 2011; 170(1):e65-73. doi: 10.1016/j.jss.2011.05.061 PMID: 21777925.
6. Hammers DW, Merritt EK, Matheny RW Jr., Adamo ML, Walters TJ, Estep JS, et al. Functional deficits and insulin-like growth factor-I gene expression following tourniquet-induced injury of skeletal muscle in young and old rats. Journal of applied physiology. 2008; 105(4):1274-81. doi: 10.1152/japplphysiol.90418.2008 PMID: 18669936; PubMed Central PMCID: PMC2576024.
7. Vignaud A, Hourde C, Medja F, Agbulut O, Butler-Browne G, Ferry A. Impaired skeletal muscle repair after ischemia-reperfusion injury in mice. Journal of biomedicine & biotechnology. 2010; 2010:724914. doi: 10.1155/2010/724914 PMID: 20467471; PubMed Central PMCID: PMC2866363.
8. James A. McEwen PKIM PhD. Surgical Tourniquet Technology Adapted for Military and Prehospital Use. NATO-RTO-MP-HFM-Proc 2004; 109:1-12. Epub 2004.
9. Cowled PA, Khanna A, Laws PE, Field JB, Fitridge RA. Simvastatin plus nitric oxide synthase inhibition modulates remote organ damage following skeletal muscle ischemia-reperfusion injury. Journal of investigative surgery: the official journal of the Academy of Surgical Research. 2008; 21(3):119-26. doi: 10.1080/08941930802046501 PMID: 18569431.
10. Deune EG, Koopman R, Smith ME, Hong SP, Ozbek MR, Khouri RK. Prevention of ischemia-reperfusion injury with a synthetic metalloprotein superoxide dismutase mimic, SC52608. Plastic and reconstructive surgery. 1996; 98(4):711-8. PMID: 8773695.
11. Bi W, Bi Y, Xue P, Zhang Y, Gao X, Wang Z, et al. Synthesis and characterization of novel indole derivatives reveal improved therapeutic agents for treatment of ischemia/reperfusion (I/R) injury. Journal of medicinal chemistry. 2010; 53(18):6763-7. doi: 10.1021/jm100529e PMID: 20731361.
12. Dillon JP, Laing AJ, Chandler JR, Wang JH, McGuinness A, Redmond HP. Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury. Acta orthopaedica. 2006; 77(1):27-32. doi: 10.1080/17453670610045669 PMID: 16534699.
13. Hammers DW, Sarathy A, Pham CB, Drinnan CT, Farrar RP, Suggs LJ. Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion. Biotechnology and bioengineering. 2012; 109(4):1051-9. doi: 10.1002/bit.24382 PMID: 22095096.
14. Goren I, Allmann N, Yogev N, Schurmann C, Linke A, Holdener M, et al. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. The American journal of pathology. 2009; 175(1):132-47. doi: 10.2353/ajpath.2009.081002 PMID: 19528348; PubMed Central PMCID: PMC2708801.
15. Segawa M, Fukada S, Yamamoto Y, Yahagi H, Kanematsu M, Sato M, et al. Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Experimental cell research. 2008; 314(17):3232-44. doi: 10.1016/j.yexcr.2008.08.008 PMID: 18775697.
16. Lu H, Huang D, Ransohoff RM, Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2011; 25(10):3344-55. doi: 10.1096/fj.10-178939 PMID: 21697550; PubMed Central PMCID: PMC3177578.
17. Lu H, Huang D, Saederup N, Charo IF, Ransohoff RM, Zhou L. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2011; 25(1):358-69. doi: 10.1096/fj.10-171579 PMID: 20889618; PubMed Central PMCID: PMC3005436.
18. Ochoa O, Sun D, Reyes-Reyna SM, Waite LL, Michalek JE, McManus LM, et al. Delayed angiogenesis and VEGF production in CCR2-/- mice during impaired skeletal muscle regeneration. American journal of physiology Regulatory, integrative and comparative physiology. 2007; 293(2):R651-61. doi: 10.1152/ajpregu.00069.2007 PMID: 17522124.
19. Shen W, Li Y, Tang Y, Cummins J, Huard J. NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. The American journal of pathology. 2005; 167(4):1105-17. doi: 10.1016/S0002-9440(10)61199-6 PMID: 16192645; PubMed Central PMCID: PMC1603662.
20. Summan M, Warren GL, Mercer RR, Chapman R, Hulderman T, Van Rooijen N, et al. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. American journal of physiology Regulatory, integrative and comparative physiology. 2006; 290(6):R1488-95. doi: 10.1152/ajpregu.00465.2005 PMID: 16424086.
21. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. American journal of physiology Regulatory, integrative and comparative physiology. 2010; 298(5):R1173-87. doi: 10.1152/ajpregu.00735.2009 PMID: 20219869; PubMed Central PMCID: PMC2867520.
22. Smith C, Kruger MJ, Smith RM, Myburgh KH. The inflammatory response to skeletal muscle injury: illuminating complexities. Sports medicine. 2008; 38(11):947-69. doi: 10.2165/00007256-200838110-00005 PMID: 18937524.
23. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature reviews Immunology. 2008; 8(12):958-69. doi: 10.1038/nri2448 PMID: 19029990; PubMed Central PMCID: PMC2724991.
24. Sachdev U, Cui X, Tzeng E. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia. Journal of vascular surgery. 2013; 58(2):460-9. doi: 10.1016/j.jvs.2012.11.071 PMID: 23414695; PubMed Central PMCID: PMC3657591.
25. Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B. Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. The FEBS journal. 2013; 280(17):4118-30. doi: 10.1111/febs.12166 PMID: 23384231.
26. Saclier M, Yacoub-Youssef H, Mackey AL, Arnold L, Ardjoune H, Magnan M, et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem cells. 2013; 31(2):384-96. doi: 10.1002/stem.1288 PMID: 23169615.
27. Chazaud B, Brigitte M, Yacoub-Youssef H, Arnold L, Gherardi R, Sonnet C, et al. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exercise and sport sciences reviews. 2009; 37(1):18-22. doi: 10.1097/JES.0b013e318190ebdb PMID: 19098520.
28. Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol AC, Poron F, et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. The Journal of cell biology. 2003; 163(5):1133-43. doi: 10.1083/jcb.200212046 PMID: 14662751; PubMed Central PMCID: PMC2173611.
29. Novak ML, Bryer SC, Cheng M, Nguyen MH, Conley KL, Cunningham AK, et al. Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration. Journal of immunology. 2011; 187(3):1448-57. doi: 10.4049/jimmunol.1004091 PMID: 21709151; PubMed Central PMCID: PMC3140545.
30. Sisson TH, Nguyen MH, Yu B, Novak ML, Simon RH, Koh TJ. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration. Blood. 2009; 114 (24):5052-61. doi: 10.1182/blood-2008-12-196212 PMID: 19812386; PubMed Central PMCID: PMC2788978.
31. Hammers DW, Rybalko V, Merscham-Banda M, Hsieh PL, Suggs LJ, Farrar RP. Anti-inflammatory macrophages improve skeletal muscle recovery from ischemia/reperfusion. J Appl Physiol (1985). 2015:jap 00313 2014. doi: 10.1152/japplphysiol.00313.2014 PMID: 25678696.
32. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. The Journal of experimental medicine. 2007; 204(5):1057-69. doi: 10.1084/jem.20070075 PMID: 17485518; PubMed Central PMCID: PMC2118577.
33. Nathan CF. Secretory products of macrophages. The Journal of clinical investigation. 1987; 79(2):319-26. doi: 10.1172/JCI112815 PMID: 3543052; PubMed Central PMCID: PMC424063.
34. Tidball JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. The Journal of physiology. 2007; 578(Pt 1):327-36. doi: 10.1113/jphysiol.2006.118265 PMID: 17038433; PubMed Central PMCID: PMC2075127.
35. Wang H, Melton DW, Porter L, Sarwar ZU, McManus LM, Shireman PK. Altered macrophage phenotype transition impairs skeletal muscle regeneration. The American journal of pathology. 2014; 184 (4):1167-84. doi: 10.1016/j.ajpath.2013.12.020 PMID: 24525152; PubMed Central PMCID: PMC3969996.
36. Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. Journal of leukocyte biology. 2013; 93(6):875-81. doi: 10.1189/jlb.1012512 PMID: 23505314; PubMed Central PMCID: PMC3656331.
37. Jetten N, Donners MM, Wagenaar A, Cleutjens JP, van Rooijen N, de Winther MP, et al. Local delivery of polarized macrophages improves reperfusion recovery in a mouse hind limb ischemia model. PloS one. 2013; 8(7):e68811. doi: 10.1371/journal.pone.0068811 PMID: 23894348; PubMed Central PMCID: PMC3722193.
38. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014; 17(1):109-18. doi: 10.1007/s10456-013-9381-6 PMID: 24013945.
39. Novak ML, Weinheimer-Haus EM, Koh TJ. Macrophage activation and skeletal muscle healing following traumatic injury. The Journal of pathology. 2014; 232(3):344-55. doi: 10.1002/path.4301 PMID: 24255005; PubMed Central PMCID: PMC4019602.
40. Bencze M, Negroni E, Vallese D, Yacoub-Youssef H, Chaouch S, Wolff A, et al. Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Molecular therapy: the journal of the American Society of Gene Therapy. 2012; 20(11):2168-79. doi: 10.1038/mt.2012.189 PMID: 23070116; PubMed Central PMCID: PMC3498804.
41. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. Journal of anatomy. 2002; 200(Pt 1):69-79. PMID: 11837252; PubMed Central PMCID: PMC1570883.
42. Merritt EK, Hammers DW, Tierney M, Suggs LJ, Walters TJ, Farrar RP. Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. Tissue engineering Part A. 2010; 16(4):1395-405. doi: 10.1089/ten.TEA.2009.0226 PMID: 19929169.
43. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nature immunology. 2002; 3(4):392-8. doi: 10.1038/ni774 PMID: 11896392.
44. Chazaud B. Macrophages: supportive cells for tissue repair and regeneration. Immunobiology. 2014; 219(3):172-8. doi: 10.1016/j.imbio.2013.09.001 PMID: 24080029.
45. Fish JS, McKee NH, Pynn BR, Kuzon WM Jr., Plyley MJ. Isometric contractile function recovery following tourniquet ischemia. The Journal of surgical research. 1989; 47(4):365-70. PMID: 2770293.
46. Fish JS, McKee NH, Kuzon WM Jr., Plyley MJ. The effect of hypothermia on changes in isometric contractile function in skeletal muscle after tourniquet ischemia. The Journal of hand surgery. 1993; 18 (2):210-7. doi: 10.1016/0363-5023(93)90348-7 PMID: 8463581.
47. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, et al. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2007; 21(7):1393-402. doi: 10.1096/fj.06-7690com PMID: 17264161.
48. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine reviews. 1996; 17(5):481-517. doi: 10.1210/edrv-17-5-481 PMID: 8897022.
49. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. The Journal of pathology. 2000; 190(3):255-66. doi: 10.1002/(SICI)1096-9896(200002)190:3〈255::AID-PATH526〉3.0.CO;2-6 PMID: 10685060.
50. Danon D, Frenkel O, Diamandstein L, Winkler E, Orenstein A. Macrophage treatment of pressure sores in paraplegia. J Wound Care. 1998; 7(6):281-3. Epub 1998/08/11. PMID: 9697460.
51. Danon D, Kowatch MA, Roth GS. Promotion of wound repair in old mice by local injection of macrophages. Proceedings of the National Academy of Sciences of the United States of America. 1989; 86 (6):2018-20. PMID: 2928316; PubMed Central PMCID: PMC286837.
52. Koh TJ, Bryer SC, Pucci AM, Sisson TH. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. American journal of physiology Cell physiology. 2005; 289(1): C217-23. doi: 10.1152/ajpcell.00555.2004 PMID: 15716324.
53. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature reviews Immunology. 2005; 5 (12):953-64. doi: 10.1038/nri1733 PMID: 16322748.
54. Keeling S, Deashinta N, Howard KM, Vigil S, Moonie S, Schneider BS. Macrophage colony stimulating factor-induced macrophage differentiation influences myotube elongation. Biological research for nursing. 2013; 15(1):62-70. doi: 10.1177/1099800411414871 PMID: 21765117.
55. Patel H, Shaw SG, Shi-Wen X, Abraham D, Baker DM, Tsui JC. Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia. Cardiology research and practice. 2012; 2012:121237. doi: 10.1155/2012/121237 PMID: 22454775; PubMed Central PMCID: PMC3290818.
56. Tonkin J, Temmerman L, Sampson RD, Gallego-Colon E, Barberi L, Bilbao D, et al. Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization. Molecular therapy: the journal of the American Society of Gene Therapy. 2015; 23 (7):1189-200. doi: 10.1038/mt.2015.66 PMID: 25896247.
57. Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, et al. TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol (1985). 2008; 104(3):694-9. doi: 10.1152/japplphysiol.00898.2007 PMID: 18187611.
58. Perdiguero E, Kharraz Y, Serrano AL, Munoz-Canoves P. MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair. Cell cycle. 2012; 11(5):877-86. doi: 10.4161/cc.11.5.19374 PMID: 22361726.
59. Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V, Jardi M, Caelles C, Serrano AL, et al. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. The Journal of cell biology. 2011; 195(2):307-22. doi: 10.1083/jcb.201104053 PMID: 21987635; PubMed Central PMCID: PMC3198158.